Tag: Windstream Holdings

  • NASDAQ active stocks: NewLead Holdings Ltd (NASDAQ:NEWL), Gilead Sciences (NASDAQ:GILD), Windstream Holdings (NASDAQ:WIN), MannKind Corporation (NASDAQ:MNKD), BlackBerry Ltd (NASDAQ:BBRY)

    On June 17,2014 NewLead Holdings Ltd. (NASDAQ: NEWL) announced that Ironridge Global IV, Ltd. (“Ironridge”) has inappropriately, again, exercised “self-help” in directing the transfer agent to issue shares to it, after conceding in court that NewLead had made an election to pay the dividend and embedded dividend liability of the Promissory Note (“Note”) in cash. NewLead Holdings Ltd (NASDAQ:NEWL) weekly performance is -63.56%. On last trading day company shares ended up $0.182. Analysts mean target price for the company is $1.00. NewLead Holdings Ltd (NASDAQ:NEWL) distance from 50-day simple moving average is -92.37%.

    Director John Francis Cogan sold 5,000 shares of the company’s stock in a transaction that occurred on Monday, June 23rd. The shares were sold at an average price of $81.82, for a total transaction of $409,100.00. The transaction was disclosed in a document filed with the SEC. Gilead Sciences, Inc. (NASDAQ:GILD) shares advanced 2.12% in last trading session and ended the day on $87.10. GILD Gross Margin is 77.80% and its return on assets is 19.10%. Gilead Sciences, Inc. (NASDAQ:GILD) quarterly performance is 17.77%.

    Windstream Holdings (NASDAQ:WIN) declared a quarterly dividend on Wednesday, May 7th. Stockholders of record on Monday, June 30th will be given a dividend of 0.25 per share on Tuesday, July 15th. This represents a $1.00 dividend on an annualized basis and a yield of 9.93%. The ex-dividend date of this dividend is Thursday, June 26th. Windstream Holdings, Inc. (NASDAQ:WIN) shares moved down -0.60% in last trading session and was closed at $9.89, while trading in range of $9.83-$9.98. Windstream Holdings, Inc. (NASDAQ:WIN) year to date performance is 30.99%.

    The U.S. Food and Drug Administration (FDA) has approved MannKind Corporation (NASDAQ:MNKD)’s inhalable insulin drug Afrezza. The approval allows diabetics to use inhalers instead of needles to control insulin levels. MannKind Corporation (NASDAQ:MNKD) ended the last trading day at $9.88. Company weekly volatility is calculated as 11.17% and price to cash ratio as 107.25. MannKind Corporation (NASDAQ:MNKD) showed a negative weekly performance of -6.70%.

    The BlackBerry Ltd (NASDAQ:BBRY) Passport is expected to launch in September 2014, marking the introduction of a large square shaped 4.5in screen with a physical keyboard.The experimental design comes as BlackBerry continues to seek a form factor to pair its well-designed physical keyboards with a large screen. Current generation devices, such as the Q10 and Q5, have screens which are limited to 3ins in size and while the Z10 has a 4in+ display, it is touch-only.BlackBerry Ltd (NASDAQ:BBRY) net profit margin is -6.73% and weekly performance is 6.81%. On last trading day company shares ended up $10.66. Analysts mean target price for the company is $10.90. BlackBerry Ltd (NASDAQ:BBRY)distance from 50-day simple moving average is 33.30%.